MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > medmira financial year 2022 over 1/2 finished

<< Previous

Bullboard Posts

Next >>

Comment by kyoung28on Feb 15, 2022 7:14pm

183 Views

Post# 34432019

RE:medmira financial year 2022 over 1/2 finished

Absolutely we need a tangible progress like SALES. Another CE approved products won’t do any good to SP.

Although I do not understand why MM didn’t pay attention to HC and missed all those golden opportunities in their own soil but suddenly went after CE approvals, I hope that they did it for reasons.
I am loosing my patience everyday and need more than just hope.

GLTA

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide